Table 3.
Parameter | RAS-TT (N = 11) | TT (N = 13) | NDT (N = 11) | ||||||
---|---|---|---|---|---|---|---|---|---|
Pre | Post | d | Pre | Post | d | Pre | Post | d | |
IMPAIRED LOWER EXTREMITY | |||||||||
Step length [m]† | 0.49 ± 0.19 | 0.60 ± 0.22 | 0.556 | 0.47 ± 0.15 | 0.54 ± 0.16 | 0.403 | 0.48 ± 0.19 | 0.59 ± 0.13 | 0.665 |
Cylce time [s] † | 1.32 ± 0.33 | 1.08 ± 0.22* | −0.824 | 1.40 ± 0.43 | 1.20 ± 0.21 | −0.623 | 1.30 ± 0.42 | 1.17 ± 0.27 | −0.365 |
Stance phase portion [%] † | 61.47 ± 4.47 | 59.16 ± 4.08 | −0.538 | 59.92 ± 4.92 | 59.88 ± 3.66 | −0.008 | 63.17 ± 8.04 | 58.76 ± 4.92 | −0.662 |
UNIMPAIRED LOWER EXTREMITY | |||||||||
Step length [m]† | 0.50 ± 0.16 | 0.62 ± 0.21 | 0.647 | 0.49 ± 0.16 | 0.58 ± 0.15* | 0.63 | 0.50 ± 0.17 | 0.60 ± 0.17 | 0.605 |
Cylce time [s]† | 1.32 ± 0.33 | 1.08 ± 0.22* | −0.834 | 1.38 ± 0.37 | 1.20 ± 0.20* | −0.63 | 1.31 ± 0.43 | 1.18 ± 0.27 | −0.378 |
Stance phase portion [%]† | 65.63 ± 6.63 | 60.29 ± 5.94* | −0.848 | 64.57 ± 5.88 | 62.15 ± 5.55 | −0.423 | 64.57 ± 7.21 | 61.76 ± 4.82 | −0.458 |
Statistically significant time effect (p < 0.05),
statistically significant differences between pre and post-intervention values (p < 0.01), d,
effect size Cohen's; , strong effect; , moderate effect; , small effect; RAS-TT, rhythmic auditory stimulation on treadmill; TT, treadmill training; NDT, neurodevelopmental treatment.